Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinoma
Aug 2026· Translational Oncology· Vol 72· 0 citations· 45 references
Medicine
TL;DR
Single-cell sequencing reveals resistance-linked malignant subcluster in LUAD, confirming oncogenic role and CoxBoost + survivalSVM model achieves optimal C-index of 0.686 across seven cohorts.
Abstract
Highlights • Single-cell sequencing reveals resistance-linked malignant subcluster in LUAD.• Cluster 2 shows hyperproliferative reprogramming with KRT17, S100A2, CST6 upregulation.• CoxBoost + survivalSVM model achieves optimal C-index of 0.686 across seven cohorts.• Low-risk patients exhibit greater immune infiltration and higher immunotherapy scores.• ARNTL2 knockdown suppresses proliferation and invasion, confirming oncogenic role.
Single-cell analysis identifies M8 fibroblast subcluster as dominant post-NACT population linked to ovarian cancer chemo-resistance and NHP2 knockdown suppresses proliferation, migration and invasion of ovarian cancer cells in vitro.
Mingqin Kuang, Chang-Mei Shen, Chun-Ping Yang et al.· Translational Oncology· 0 citations
The constructed RSF model offers a promising computational framework for risk stratification and provides hypothesis-generating insights that may inform future personalized treatment strategies for HCC patients, suggesting a profound link with single-cell metabolic‒immune crosstalk.
High-resolution mapping of 52,384 cells uncovers hierarchical intra-tumor heterogeneity in HCC and TMEM176B is identified as the link between tumor malignancy hierarchy and immune remodeling.
Hong Chen, Jian-Feng Gong, De-Ying He et al.· Translational Oncology· 0 citations
Highlights • Single-cell transcriptomic profiling of multicenter pancreatic cancer radiotherapy cohorts identified PLPP2 as a key driver of radiotherapy resistance and immune microenvironment remodeling.• Random forest model identified PLPP2 as an important marker for promoting malignant progression, immune dysregulati...
Yi-Fei Wang, Parhat Kaysar, Yi-Jian Ma et al.· Translational Oncology· 0 citations
Highlights • Constructed a two-gene (ITM2A/TCL1A) prognostic model linking adaptive immunity and radiosensitivity in cervical cancer.• Identified ITM2A and TCL1A as radiosensitizers; their downregulation promotes radioresistance.• Risk groups differ in immune infiltration, chemokine/TCR signaling, and immunotherapy res...